New & Noteworthy

Jan 02, 2018
For the pharma sector across Europe, Brexit is just one of the tough issues to think about in 2018, writes Reflector.
Dec 31, 2017
Enacting landmark tax reform legislation that makes major changes in the corporate tax structure was Congress's Christmas present to President Trump — and to industry, writes Jill Wechsler.
Dec 30, 2017
Pharmaceutical Executive
Pharm Exec details the latest approaches to combating disease and health crises on a global scale—including industry perspectives from those involved on the front lines.
Dec 29, 2017
Pharmaceutical Executive
Amid a widening net of health threats worldwide, alliances forged in research and response may be more critical than ever to stem the tide.
Dec 22, 2017
Kilian Weiss talks to Pharm Exec about the modern challenges of identifying KOLs in oncology, and why technology can offer a solution to this vital process.
Dec 18, 2017
Pharmaceutical Executive
With over 70 companies manufacturing immediate-release opioids in the United States, federal regulators may look to limit marketing to reduce the prescription and over-prescription of opioids.
Dec 12, 2017
Pharmaceutical Executive
Figuring out the right formula to address global health—for the better.
Dec 11, 2017
Pharmaceutical Executive
Groundbreaking treatment approaches call for innovative commercialization strategies.
Dec 11, 2017
Pharmaceutical Executive
In 2017, patients gained access to the first gene therapies and more orphan and breakthrough drugs.
Dec 10, 2017
Pharmaceutical Executive
How Ruud Dobber is steering AstraZeneca’s US course as it navigates the complexities of a fast-evolving therapeutic market.
native1_300x100
lorem ipsum